Hsa-miRNA-143-3p Reverses Multidrug Resistance of Triple-Negative Breast Cancer by Inhibiting the Expression of Its Target Protein Cytokine-Induced Apoptosis Inhibitor 1 In Vivo

PURPOSE: Multidrug resistance (MDR) remains a major obstacle in the treatment of triple-negative breast cancer (TNBC) with conventional chemotherapeutic agents. A previous study demonstrated that hsa-miRNA-143-3p plays a vital role in drug resistance of TNBC. Downregulation of hsa-miRNA-143-3p upreg...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Yu Wei, Hao, Wen Jing, Li, Yi Wen, Li, Yi Xin, Zhao, Bo Chen, Lu, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158160/
https://www.ncbi.nlm.nih.gov/pubmed/30275853
http://dx.doi.org/10.4048/jbc.2018.21.e40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158160/
https://www.ncbi.nlm.nih.gov/pubmed/30275853
http://dx.doi.org/10.4048/jbc.2018.21.e40

Ejemplares similares